Retatrutide 10mg Vial

Sold out
Retatrutide 10mg Vial
$130.00

Overview
Retatrutide (LY3437943) is a cutting-edge investigational peptide classified as a triple hormone receptor agonist, targeting GLP-1, GIP, and glucagon receptors. This multi-pathway mechanism makes it a promising candidate for research into obesity, type 2 diabetes, and metabolic syndrome. 

Key Features

  • Formulation: Lyophilized powder
  • Concentration: 10mg per vial
  • Purity: ≥99%, third-party tested
  • Storage: Store at -4°F (lyophilized); once reconstituted, refrigerate at 36–46°F and use within 30 days 
  • CAS Number: 2381089-83-2
  • Molecular Formula: C227H354N48O69
  • Molecular Weight: 4860 g/mol 

Mechanism of Action
Retatrutide activates three key receptors:

  • GLP-1: Enhances insulin secretion and reduces appetite
  • GIP: Supports insulin sensitivity and energy balance
  • Glucagon: Promotes fat metabolism and energy expenditure 

This synergistic activity has shown promise in delaying gastric emptying, reducing body weight, and improving glycemic control in early-phase clinical trials. 

Research Applications

  • Obesity and weight management
  • Glucose regulation in type 2 diabetes
  • Metabolic syndrome studies
  • Energy expenditure and hormonal balance 

Packaging 

  • Supplied in sterile, unbranded vials for wholesale distribution

Compliance Notice:

  • For laboratory research use only
  • Not for human or veterinary consumption